Multiple Myeloma /

Should Antibodies be a Standard Agent Included in Regimens for First Relapse? Sagar Lonial, MD, FACP vs. Kenneth Anderson, MD #ASH20

21:49

Multiple Myeloma

Multiple Myeloma Similar Videos

Similar Videos

Madhav Dhodapkar, MBBS; Emory University Winship Cancer Institute; #DDHO2022

12:52
Module 2_BCMA-Targeted CAR T-cells

24:20
Module 3_BCMA-Targeted Antibody-Drug Conjugates (ADCs)

9:40

ABOUT

Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.

The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.

CONNECT

support@bioascend.com

(888) 476-9129

980 North Michigan Avenue, Suite 1400, Chicago, IL 60611